O-RAN-ALLIANCE
The O-RAN Global PlugFest Fall 2022 was successfully completed in 6 venues across Asia, Europe, and North America, with 106 participating companies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005850/en/
O-RAN ALLIANCE global PlugFests represent a major platform enabling efficient progress of the O-RAN ecosystem through well-organized testing and integration. O-RAN Global PlugFest Fall 2022 is the second O-RAN PlugFest this year. In combination with the Spring PlugFest, the 2022 O-RAN Global PlugFests span across 9 venues with 156 participants, of which many participated at more than one venue.
“Testing and integration at O-RAN PlugFests show increasing maturity of O-RAN technology in all regions,” said Linsheng Liao, O-RAN TIFG Co-chair and Senior Project Manager of CMRI. “Comparing the PlugFest results year to year, we are pleased to see major progress made by the O-RAN ecosystem in conformance and interoperability tests, as well as more advanced end-to-end and network automation scenarios. O-RAN PlugFests greatly contribute to developing commercially available O-RAN networks.”
O-RAN Global PlugFest Fall 2022 in Asia
PlugFest in Japan, hosted by NTT DOCOMO, KDDI, Rakuten Mobile, SoftBank, YRP and YRP R&D Promotion Committee took place at multiple sites in large metropolitan area. Activities focused on:
- Lab tests and field trials of latency assurance with Near-RT RIC for E2E network slicing
- Conformance, IOT, E2E testing, including Open Fronthaul and security verification
- Field tests of mmW backhaul system using O-RAN Fronthaul
- Multi-vendor vRAN integration
- Near-RT RIC demo with xApp and E2 nodes
- Open source demo realizing vRAN application deployment with OpenStack Tacker
In addition to the hosts, participants included AMD AECG, Anritsu, ComWorth, Dell Technologies, DKK, DZS, Fujitsu, HCL, Keysight Technologies, KYOCERA, NEC, NVIDIA, Red Hat, Spirent, TOYO, VIAVI Solutions and Wind River.
PlugFest in South Korea hosted by LG Uplus focused on:
- 5G O-RAN in-building field trial
- 5G O-RAN Lab validation
- Test scenarios including fronthaul conformance test, E2E test, analysis of fronthaul and midhaul interfaces
- Validation of RIC use case with xApp/rApp and the open interfaces (O1, A1, and E2)
In addition to the hosts, participants included Ciena, DELL Technologies, ETRI, Innowireless, Juniper Networks, Keysight Technologies and Viettel High Technology Industries.
PlugFest in South Korea hosted by SK Telecom focused on:
- Open Fronthaul interface conformance testing for O-DU and O-RU
- O-RAN specified interoperability testing between O-DU and O-RU
- Evaluation of O-RAN based private 5G systems through O-RAN specified E2E tests
- Performance and functional testing in live indoor environments
In addition to the hosts, participants included ETRI, Hewlett Packard Enterprise, HFR, Intel and Keysight Technologies.
O-RAN Global PlugFest Fall 2022 in Europe
Deutsche Telekom, EANTC, EURECOM, Orange, TIM, Vodafone and BT have teamed up together with Telecom Infra Project (TIP) to host the Joint European O-RAN & TIP PlugFest Fall 2022. The PlugFest was hosted in four European labs, namely EURECOM in Sophia Antipolis, i14y Lab in Berlin, Orange Lab in Paris and TIM Innovation Lab in Torino.
The joint PlugFest has demonstrated complementarities and synergies between O-RAN and TIP as well as between the labs.
Test scenarios focused on:
- Conformance testing of Open Fronthaul interface of O-RU and O-DU
- End-to-end multi-vendor integration with functional and performance testing
- xApps/rApps integration with Near/Non-RT RICs and xApps/rApps functional verification
- O-Cloud platform performance testing
In addition to the hosts, participants included Aarna Networks, Accelleran, ADVA Optical Networking, Analog Devices, Anritsu, Aspire Technology, Azcom Technology, Calnex Solutions, Capgemini Engineering, Dell Technologies, DZS, Fujitsu, Hewlett Packard Enterprise, highstreet technologies, JMA Wireless, Juniper Networks, Keysight Technologies, Mavenir, Microamp Solutions, MTI, NEC, Net AI, Nokia, Open Networking Foundation, Radisys, Red Hat, Rimedo Labs, Rohde & Schwarz, SIAE MICROELETTRONICA, SOLiD, Spirent, VIAVI Solutions, VMware and VoerEir.
O-RAN Global PlugFest Fall 2022 in North America
PlugFest in North America hosted by CableLabs at the Kyrio OTIC Lab focused on:
- Multi-vendor O-RAN end-to-end system under test, based on the O-RAN E2E test specification, demonstrating cell capacity for signaling and user-plane traffic load. Moreover, the Fronthaul delay impact on user peak throughput was measured using Fronthaul impairment emulators.
- Demonstration of O-CU interoperability, based on the O-RAN IOT test specifications, verified traffic scenarios across emulated F1 and Xn interfaces, as well as the open F1 and Xn protocol implementation. In addition, the O-CU demonstrated successful interoperability for F1AP and XnAP global, elementary, and mobility procedures.
- Near-RT RIC testing for conformance to the O-RAN E2 interface specification (E2AP, E2 SM, E2 SM RC, and E2 SM KPM procedures) were verified following the E2 test specification. Moreover, a QoS xApp was integrated and tested.
In addition to the hosts, participants included Calnex Solutions, Capgemini Engineering, Lumentum Holdings, Radisys Networks, Sunwave Communications, VIAVI Solutions and Xena Networks.
PocFest in North America hosted by UNH-IOL, hosted by AT&T and DISH, took place in four labs:
- University of New Hampshire InterOperability Lab
- TIP Community Lab at Meta, Menlo Park CA
- POWDER Lab and NSF PAWR SITE with the University of Utah
- COSMOS Lab and NSF PAWR SITE with the Rutgers University, Columbia University, NYU Wireless
Activities focused on testing of conformance and performance of O-RU devices, measurements of energy saving and efficiency, integration of AI/ML for resource pooling and slicing, testing of RIC, xApps, SMO, and end-to-end interoperability testing.
In addition to the hosts, participants included AMD, Anritsu, Calnex, DZS, Fujitsu, HCL, Intel, Keysight Technologies, NEC, Radisys, Rohde & Schwarz, VIAVI Solutions, VVDN, VMware, Vodafone, Wind River and Xena.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 330 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005850/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Begins Commercialization of BYOOVIZ®, Biosimilar to Lucentis (Ranibizumab), in Europe2.1.2026 08:00:00 CET | Press release
Samsung Bioepis completes full transfer of commercial rights from Biogen back to Samsung Bioepis for BYOOVIZ®BYOOVIZ becomes the fourth biosimilar directly commercialized by Samsung Bioepis in Europe, following EPYSQLI® (eculizumab), OBODENCE® (denosumab), and XBRYK® (denosumab)Pre-filled syringe (PFS) presentation to become available in Europe in the second quarter of 2026 Samsung Bioepis Co., Ltd. today announced that the company has begun direct commercialization of BYOOVIZ®, a biosimilar to Lucentis1 (ranibizumab), in Europe. Samsung Bioepis has been working to ensure seamless transfer of commercial rights from Biogen back to Samsung Bioepis, and BYOOVIZ will now be available as a Samsung Bioepis brand across multiple European countries. “This is a significant milestone for Samsung Bioepis as the company continues to strengthen its presence in Europe by expanding its portfolio of directly commercialized products. Leveraging the past three years of experience with EPYSQLI (eculizuma
Cessna Citation Ascend Enters Into Service, Redefining Performance and Cabin Experience in the Midsize Business Jet Market31.12.2025 15:00:00 CET | Press release
The Cessna Citation Ascend achieved a major milestone as the first retail customer took delivery of the midsize business jet on Tuesday, December 30, marking the aircraft’s entry into service. Announced in 2023 the aircraft boasts an entirely new cockpit, improved performance and a luxurious flat floor cabin. The Citation Ascend received type certification from the Federal Aviation Administration (FAA) in November 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251231586042/en/ Cessna Citation Ascend enters into service, redefining performance and cabin experience in the midsize business jet market. (Photo credit: Textron Aviation) The Cessna Citation Ascend is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “The first Citation Ascend delivery underscores Textron Aviation’s commitment to redefining the midsize segment with an aircraft that blends innovation, efficiency and unmatch
Aster Guardians Global Nursing Award 2026 Worth $250,000 Extends Deadline Till 11th January 202631.12.2025 14:08:00 CET | Press release
Due to an extraordinary global response of over 134,000 registrations from 214 countries, the submission deadline has been extended.Nurses worldwide can submit their nominations via www.asterguardians.com The Aster Guardians Global Nursing Award 2026, an initiative from Aster DM Healthcare – a leading integrated healthcare provider, has announced the extension of its deadline to January 11, 2026. The awards have already received over 134,000 registrations from 214 countries, highlighting its growing global reach and recognition among nurses worldwide. Nurses from around the world can submit their nominations through the dedicated platform at www.asterguardians.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251231986766/en/ Aster Guardians Global Nursing Award worth USD 250,000 (Photo: AETOSWire) This year, the prestigious award will be hosted in New Delhi, India, celebrating nursing excellence on a truly global stage. T
Tecnotree Included as a Representative Provider in Gartner® Innovation Insight: AI SOC Agents Accelerate CSP SecOps Transformation31.12.2025 11:59:00 CET | Press release
Tecnotree, a global digital platform and services provider for communications service providers (CSPs), today announced that it has been referenced as a Representative Provider alongside Google, Anthropic, Dropzone AI, DRUID, Palo Alto Networks, and Pegasystems in the Gartner® Innovation Insight: “AI SOC Agents Accelerate CSP SecOps Transformation,” published in December 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251231210303/en/ Tecnotree Included as a Representative Provider in Gartner® Innovation Insight: AI SOC Agents Accelerate CSP SecOps Transformation The Gartner Innovation Insight examines the emerging role of AI-driven Security Operations Centre (SOC) agents in CSP environments, outlining how these agents are used to automate and augment security operations across signalling, core networks, RAN, Open RAN, and roaming domains. The research discusses use cases such as alert triage, investigation support, thr
UAE’s Medcare Treats First International SMA Patient With Revolutionary Intrathecal Gene Therapy30.12.2025 15:15:00 CET | Press release
The newly licensed intrathecal gene therapy expands life-changing treatment options for children and adults affected by SMA Medcare Women & Children Hospital has successfully administered a pioneering intrathecal gene therapy for Spinal Muscular Atrophy (SMA) to Hulus, a three-year-old patient from Turkey. This milestone positions Medcare among the first private healthcare providers worldwide to offer this innovative treatment to an older international patient, overcoming previous age and weight limitations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251230695275/en/ World's first international patient, who received intrathecal gene therapy at Medcare Royal Hospital in Dubai, UAE, along with parents, and the hospital team. (Photo: AETOSWire) SMA is a rare neuromuscular disorder that progressively weakens muscles responsible for movement and breathing. This newly licensed one-time therapy addresses the root genetic cause
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
